Treatment of Lung Hemangioma in Israel with an Individualized Program Including Progressive Methods

Timely implementation of an adequate therapeutic course eliminates symptoms, prevents the development of life-threatening complications, and in most cases ensures a positive prognosis. The high-tech equipment of diagnostic centers in Israel and progressive research methods allow for the rapid detection of tumors at the earliest stages of development, establishing their characteristic features, and selecting effective therapy methods for each patient. Additionally, a comprehensive examination of the thoracic organs is performed to assess structural and functional pathological changes.

Treatment Methods for the Disease

Lung hemangioma is diagnosed in a small number of patients, primarily in older children and adults. This benign vascular tumor develops in the bronchial tree or lung due to changes in mesodermal cells. The tumor is surrounded by a dense capsule, clearly delineated from the surrounding lung tissues, develops slowly, and does not have a tendency for malignant transformation. The size of the hemangioma varies from 2-3 millimeters to 20-23 centimeters.

The main causes of the disease are related to disruptions occurring during intrauterine development. However, it has been proven that the risk of developing lung hemangioma in newborns significantly increases in cases of maternal infection with pathogenic bacterial and viral agents, hormonal medication intake, and some other medications. In adulthood, the tumor process may be stimulated by exposure to ultraviolet rays (frequent prolonged sun exposure, visiting tanning salons) and vascular pathologies.

Depending on their characteristics, hemangiomas are classified into the following types:

• by location — intrapulmonary (most common) and endobronchial, central or peripheral;
• by the number of identified hemangiomas — solitary and multiple;
• by the volume of involvement — unilateral and bilateral.

Symptoms are determined by the characteristics and stage of tumor development. Since hemangiomas develop quite slowly, clinical signs may not manifest for a long time, in some cases — for many years. Usually, painful symptoms indicate the development of serious complications. Patients may experience chest pain, hemoptysis, and a high likelihood of spontaneous pulmonary hemorrhage. Chronic oxygen deficiency and resulting hypoxemia lead to shortness of breath, dizziness, and cyanosis of the skin. In children, growth and physical development delays are observed.

The greatest danger is posed by the rupture of the tumor, usually caused by traumatic injuries or significant ulceration of the tumor surface. In this case, there is a high probability of massive pulmonary hemorrhage, for which urgent surgical assistance is required to eliminate and save the patient. If pathogenic agents penetrate the tissues of the hemangioma with numerous ulcers, a purulent inflammatory process develops in the lung.

Surgical Treatment

A positive effect is achieved only through surgical removal of the tumor. The hemangioma is resected within normal tissues.

• Final bronchial resection — a surgical intervention in which the affected segment of the bronchial wall is resected. The disrupted integrity of the bronchus is restored during a reconstructive operation, which involves closing the defect with a skin flap or a fragment of the venous vessel wall, using surgical sutures. This procedure is indicated in cases of small endobronchial hemangiomas.
• Circular bronchial resection — excision of the segment of the bronchus involved in the pathological process, followed by restoration of the integrity of the bronchial wall using anastomosis. This surgical technique is also indicated only at the early stages of the disease, before the tumor has reached a large size.
• Lobectomy — resection of the pathologically altered lobe of the lung during an open operation. Stages of the intervention include opening the chest (thoracotomy) and pleural cavity, resection of the lobe of the lung, and cavity sanitation, placement of drains.
• Pneumonectomy — complete surgical removal of the lung performed under general anesthesia, either thoracotomically (open) or minimally invasively (thoracoscopically). In Israeli clinics, the operation is most often performed thoracoscopically, which has advantages such as low trauma and absence of complications, and a shortened postoperative period.

In cases of multiple involvement of both lungs, the identified tumors are resected. For positive results, surgical removal of the tumor should be performed at the early stages, provided the tumor is small and there are no irreversible pathological changes in the lung tissues.

Hemotransfusion

In the event of massive pulmonary hemorrhage and significant blood loss, donor blood, plasma elements, and blood substitutes are transfused to the patient.

Dynamic Observation

In elderly patients with hemangiomas localized in the peripheral area of the lung, in the absence of pronounced symptoms and complications, the course of specific therapy is replaced with a wait-and-see approach. The patient regularly visits consultations with the treating pulmonologist and undergoes comprehensive examinations, which allows for timely diagnosis of disease progression.

Methods of Diagnosing the Disease

In Israel, the necessary consultations with specialists and examinations for diagnosis and therapeutic program development take approximately three days.

What is the Cost of Treatment for the Disease

Advantages of Treatment in Israel

• Excellent training and extensive experience of doctors.
• Availability of high-precision equipment.
• Professional execution of minimally invasive endoscopic surgeries.
• Comfortable conditions.
• Affordable prices.

Complete recovery and restoration of impaired functions are possible only with timely medical assistance. Without wasting time, contact your chosen clinic as soon as possible and begin treatment.